Using GSEA, we identified enriched biological processes and pathways, well established in SLE, such as interferon (IFN) type I response and interleukin (IL) production (i.e., IL1, IL2, IL8, and IL12) (46, 47). The gene discussed is CXCL8; the disease is systemic lupus erythematosus.